Fig. 1 · Structure
Documents & Downloads
Glycyl-Exatecan TFA
Anticancer Agent
Glycyl-Exatecan TFA targets DNA topoisomerase I and functions as an effective anticancer agent. This compound exhibits significant antitumor activity, making it a valuable tool in cancer research. Glycyl-Exatecan TFA is particularly applicable in studies focusing on solid tumors, aiding in the exploration of therapeutic strategies for various malignancies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1883333-57-0 |
| Applications | Anticancer Agent |
| Formula | C28H26F4N4O7 |
| Molecular Weight | 606.52 |
| Synonyms | Glycyl-DX-8951 TFA; Exatecan analog 2 TFA |
| SMILES | O=C(N[C@H]1CCC2=C3C1=C(CN4C(C(COC([C@@]5(CC)O)=O)=C5C=C46)=O)C6=NC3=CC(F)=C2C)CN.O=C(O)C(F)(F)F |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.